BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 12, Issue 23
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5103)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-8) series.
Item 
Count 
PDF550
HTML4339
Tables (1-8)214
 Sum=5103
Jun 21, 2006 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12(23): 3682-3694 [PMID: 16773685 DOI: 10.3748/wjg.v12.i23.3682]
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3682.htm
Number Citing Articles
1
AM Attallah, MS Albannan, MM Omran, R Zayed, S Saif, A Farid, M Hassany, A Yosry, D Omran. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. British Journal of Biomedical Science 2019; 76(3): 105 doi: 10.1080/09674845.2019.1600325
2
Maria AL de Carli, Luiz A. de Carli, Marcos B. Correa, Gerson Junqueira, Cristiane Valle Tovo, Gabriela P. Coral. Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2020; 32(3): 420 doi: 10.1097/MEG.0000000000001519
3
Salimur Rahman, Mamun Al-Mahtab, Mohammad Sayedul Haque, Sharmin Sultana, Ayub Al-Mamun. The Value of Serum CA19-9 Levels in predicting Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis B. Euroasian Journal of Hepato-Gastroenterology 2015; 5(1): 16 doi: 10.5005/jp-journals-10018-1122
4
L.C. Mendes, P.A. Ferreira, N. Miotto, L. Zanaga, E. Gonçales, M.S. Lazarini, F.L. Gonçales Júnior, R.S.B. Stucchi, A.G. Vigani. Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C. Brazilian Journal of Medical and Biological Research 2016; 49(9) doi: 10.1590/1414-431x20165432
5
Yen Ngo, Yves Benhamou, Vincent Thibault, Patrick Ingiliz, Mona Munteanu, Pascal Lebray, Dominique Thabut, Rachel Morra, Djamila Messous, Frederic Charlotte, Françoise Imbert-Bismut, Dominique Rousselot-Bonnefont, Joseph Moussalli, Vlad Ratziu, Thierry Poynard, Niyaz Ahmed. An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load. PLoS ONE 2008; 3(7): e2573 doi: 10.1371/journal.pone.0002573
6
Ashraf Elfakhry, Ehab Abdel-Khalek, Sahar El-Gharabawy, Eman El-Tanaihy, Azza Abdelbaky. Predictive value of the adiponectin to leptin ratio for diagnosis of steatohepatitis in patients with nonalcoholic fatty liver disease. Egyptian Liver Journal 2013; 3(2): 47 doi: 10.1097/01.ELX.0000427107.63804.34
7
Dalia Omran, Rania A. Zayed, Mohammed M. Nabeel, Lamiaa Mobarak, Zeinab Zakaria, Azza Farid, Mohamed Hassany, Sameh Saif, Muhammad Mostafa, Omar Khalid Saad, Ayman Yosry. Evaluating Diagnostic Accuracy of Noninvasive Tests in Assessment of Significant Liver Fibrosis in Chronic Hepatitis C Egyptian Patients. Viral Immunology 2018; 31(4): 315 doi: 10.1089/vim.2017.0134
8
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. . Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
9
El-Shahat A. Toson, Gamal E. Shiha, Hatem A. El-mezayen, Waleed Samir, Mohamed M. El-khininy. Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients: angiogenic fibrogenic link. European Journal of Gastroenterology & Hepatology 2017; 29(2): 199 doi: 10.1097/MEG.0000000000000775
10
Laurent Castera, Xavier Forns, Alfredo Alberti. Non-invasive evaluation of liver fibrosis using transient elastography. Journal of Hepatology 2008; 48(5): 835 doi: 10.1016/j.jhep.2008.02.008
11
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten. Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. World Journal of Hepatology 2011; 3(8): 219-227 doi: 10.4254/wjh.v3.i8.219
12
Flavia Bortolotti, Maria Guido. Reversal of Liver Cirrhosis: A Desirable Clinical Outcome and Its Pathogenic Background. Journal of Pediatric Gastroenterology and Nutrition 2007; 44(4): 401 doi: 10.1097/MPG.0b013e318032069a
13
Abdelfattah M. Attallah, Mohamed El‐Far, Mohamed M. Omran, Khaled Farid, Mohamed S. Albannan, Ibrahim El‐Dosoky. Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C Patients. Journal of Clinical Laboratory Analysis 2013; 27(2): 121 doi: 10.1002/jcla.21572
14
Laurent Castéra, Giada Sebastiani, Brigitte Le Bail, Victor de Lédinghen, Patrice Couzigou, Alfredo Alberti. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C. Journal of Hepatology 2010; 52(2): 191 doi: 10.1016/j.jhep.2009.11.008
15
Thomas Pembroke, Giada Sebastiani. Diagnostic Methods for Cirrhosis and Portal Hypertension. 2018; : 63 doi: 10.1007/978-3-319-72628-1_5
16
Thierry Poynard, Rachel Morra, Philippe Halfon, Laurent Castera, Vlad Ratziu, Françoise Imbert-Bismut, Sylvie Naveau, Dominique Thabut, Didier Lebrec, Fabien Zoulim, Marc Bourliere, Patrice Cacoub, Djamila Messous, Mona Munteanu, Victor de Ledinghen. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterology 2007; 7(1) doi: 10.1186/1471-230X-7-40
17
Shallu Tomer, SunilK Arora. A juggernaut of innate & adaptive immune cells in chronic hepatitis C. Indian Journal of Medical Research 2020; 151(4): 279 doi: 10.4103/ijmr.IJMR_1387_17
18
Philippe Halfon, Yannick Bacq, Anne De Muret, Guillaume Penaranda, Marc Bourliere, Denis Ouzan, Albert Tran, Danielle Botta, Christophe Renou, Marie-Claude Bréchot, Claude Degott, Valérie Paradis. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. Journal of Hepatology 2007; 46(3): 395 doi: 10.1016/j.jhep.2006.09.020
19
Jayant A. Talwalkar, Meng Yin, Jeff L. Fidler, Schuyler O. Sanderson, Patrick S. Kamath, Richard L. Ehman. Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications. Hepatology 2007; 47(1): 332 doi: 10.1002/hep.21972
20
M. Bourlière, G. Pénaranda, X. Adhoute, V. Oules, P. Castellani. Combining non-invasive methods for assessment of liver fibrosis. Gastroentérologie Clinique et Biologique 2008; 32(6): 73 doi: 10.1016/S0399-8320(08)73996-4
21
G. Sebastiani, A. Alberti. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?. Journal of Viral Hepatitis 2012; 19(s1): 18 doi: 10.1111/j.1365-2893.2011.01518.x
22
Henrique S. T. Correia, Ana Lucia C. Domingues, Edmundo P. A. Lopes, Clarice N. L. Morais, Camila Sarteschi, Izolda M. F. Moura. Níveis séricos de globulinas e a intensidade da fibrose hepática em pacientes com esquistossomose mansônica. Arquivos de Gastroenterologia 2009; 46(3): 194 doi: 10.1590/S0004-28032009000300010
23
Waqar Ahmad, Bushra Ijaz, Sana Gull, Sultan Asad, Saba Khaliq, Shah Jahan, Muhammad T Sarwar, Humera Kausar, Aleena Sumrin, Imran Shahid, Sajida Hassan. A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-53
24
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges. 2017;  doi: 10.5772/intechopen.68317
25
Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten, Zeynep Bıyıklı. Non-alcoholic steatohepatitis with normal aminotransferase values. World Journal of Gastroenterology 2009; 15(15): 1863-1868 doi: 10.3748/wjg.15.1863
26
Ramin Jafari, Stefanie J. Hectors, Anne K. Koehne de González, Pascal Spincemaille, Martin R. Prince, Gary M. Brittenham, Yi Wang. Integrated quantitative susceptibility and R2* mapping for evaluation of liver fibrosis: An ex vivo feasibility study. NMR in Biomedicine 2021; 34(1) doi: 10.1002/nbm.4412
27
Wilma Debernardi-Venon, Silvia Martini, Fiorella Biasi, Barbara Vizio, Angela Termine, Giuseppe Poli, Franco Brunello, Carlo Alessandria, Renato Bonardi, Giorgio Saracco, Mario Rizzetto, Alfredo Marzano. AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers. Journal of Hepatology 2007; 46(6): 1026 doi: 10.1016/j.jhep.2007.01.017
28
Ying Qu, Chun-Fang Gao, Kun Zhou, Yun-Peng Zhao, Ming-Yi Xu, Lun-Gen Lu. Serum N-glycomic markers in combination with panels improves the diagnosis of chronic hepatitis B. Annals of Hepatology 2012; 11(2): 202 doi: 10.1016/S1665-2681(19)31025-7
29
Laurent Castera, Jacques Denis, Gerard Babany, Françoise Roudot-Thoraval. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?. Journal of Hepatology 2007; 46(3): 528 doi: 10.1016/j.jhep.2006.12.002
30
A. Maieron, P. Salzl, M. Peck‐Radosavljevic, M. Trauner, S. Hametner, R. Schöfl, P. Ferenci, M. Ferlitsch. Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C . Alimentary Pharmacology & Therapeutics 2014; 39(3): 331 doi: 10.1111/apt.12564
31
Catherine Jane Messner, Saskia Schmidt, Dilek Özkul, Carine Gaiser, Luigi Terracciano, Stephan Krähenbühl, Laura Suter-Dick. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. International Journal of Molecular Sciences 2021; 22(18): 9799 doi: 10.3390/ijms22189799
32
Giada Sebastiani, Kostas Pantopoulos. Cellular and Molecular Biology of Metals. 2010; : 351 doi: 10.1201/9781420059984-c13
33
Rachel Morra, Mona Munteanu, Françoise Imbert-Bismut, Djamila Messous, Vlad Ratziu, Thierry Poynard. FibroMAX™: towards a new universal biomarker of liver disease?. Expert Review of Molecular Diagnostics 2007; 7(5): 481 doi: 10.1586/14737159.7.5.481
34
Pierre Brissot, Marie-Bérengère Troadec, Edouard Bardou-Jacquet, Caroline Le Lan, Anne-Marie Jouanolle, Yves Deugnier, Olivier Loréal. Current approach to hemochromatosis. Blood Reviews 2008; 22(4): 195 doi: 10.1016/j.blre.2008.03.001
35
Cumali Efe, Mustafa Cengiz, Evrim Kahramanoğlu-Aksoy, Bülent Ylmaz, Burak Özşeker, Yavuz Beyazt, Alpaslan Tanoğlu, Tugrul Purnak, Taylan Kav, Turan Turhan, Seren Ozenirler, Ersan Ozaslan, Staffan Wahlin. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis. European Journal of Gastroenterology & Hepatology 2015; 27(6): 649 doi: 10.1097/MEG.0000000000000355
36
Eylem Levelt, Michael Pavlides, Rajarshi Banerjee, Masliza Mahmod, Catherine Kelly, Joanna Sellwood, Rina Ariga, Sheena Thomas, Jane Francis, Christopher Rodgers, William Clarke, Nikant Sabharwal, Charalambos Antoniades, Jurgen Schneider, Matthew Robson, Kieran Clarke, Theodoros Karamitsos, Oliver Rider, Stefan Neubauer. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes. Journal of the American College of Cardiology 2016; 68(1): 53 doi: 10.1016/j.jacc.2016.03.597
37
G. Sebastiani, A. Vario, M. Guido, A. Alberti. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. Journal of Viral Hepatitis 2008; 15(3): 212 doi: 10.1111/j.1365-2893.2007.00932.x
38
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosis. World Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
39
Mohammed Abd El-Hamid El-Bokl, Shadia Mabrouk, Nanees Ahmed Adel Abd El-Mageed, Nermine Helmy Mahmoud, Sherif Sadek Shabana. Do serum CA 19-9 and CA 125 levels predict the severity of HCV-related liver fibrosis?. Egyptian Liver Journal 2011; 1(1): 33 doi: 10.1097/01.ELX.0000397025.95176.ca
40
Zhong Liu, Bin Huang, Huiying Wen, Zhicheng Lu, Qicai Huang, Meiqin Jiang, Changfeng Dong, Yingxia Liu, Xin Chen, Haoming Lin. Automatic Diagnosis of Significant Liver Fibrosis From Ultrasound B-Mode Images Using a Handcrafted-Feature-Assisted Deep Convolutional Neural Network. IEEE Journal of Biomedical and Health Informatics 2023; 27(10): 4938 doi: 10.1109/JBHI.2023.3295078
41
José Tadeu Stefano, Laura Vilar Guedes, Arthur Alencar Arrais de Souza, Denise Siqueira Vanni, Venâncio Avancini Ferreira Alves, Flair José Carrilho, Alvaro Largura, Marco Arrese, Claudia P. Oliveira. Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. Annals of Hepatology 2021; 20: 100253 doi: 10.1016/j.aohep.2020.08.070
42
Nurten Nur Aydın, İftihar Köksal. An Evaluation of Chronic Hepatitis C Patients’ Responses to Direct-Acting Antivirals According to Transient Elastography and Serum Biomarkers. Viral Hepatitis Journal 2022; 28(1): 18 doi: 10.4274/vhd.galenos.2022.2021-8-2
43
Jordi Camps, Judit Marsillach, Jorge Joven. The paraoxonases: role in human diseases and methodological difficulties in measurement. Critical Reviews in Clinical Laboratory Sciences 2009; 46(2): 83 doi: 10.1080/10408360802610878
44
A. Cequera, M.C. García de León Méndez. Biomarkers for liver fibrosis: Advances, advantages and disadvantages. Revista de Gastroenterología de México (English Edition) 2014; 79(3): 187 doi: 10.1016/j.rgmxen.2014.07.001
45
Vasiliy Ivanovich Reshetnyak. Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis. World Journal of Gastroenterology 2015; 21(25): 7683-7708 doi: 10.3748/wjg.v21.i25.7683
46
Gamal Shiha, Nasser Mousa. Liver Diseases. 2020; : 427 doi: 10.1007/978-3-030-24432-3_36
47
Minjie Wan, Hongqin Xu, Dezhao Li, Le Wang, Xu Li. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI). Medicine 2021; 100(6): e24723 doi: 10.1097/MD.0000000000024723
48
Saurabh Sethi, Douglas A Simonetto, Soha S Abdelmoneim, Michael B Campion, Irakli Kaloiani, Amy C Clayton, Walter K Kremers, Kevin C Halling, Patrick S Kamath, Jayant Talwalkar, Vijay H Shah. Comparison of Circulating Endothelial Cell/Platelet Count Ratio to Aspartate Transaminase/Platelet Ratio Index for Identifying Patients with Cirrhosis. Journal of Clinical and Experimental Hepatology 2012; 2(1): 19 doi: 10.1016/S0973-6883(12)60078-4
49
Daiki Suzuki, Koyo Yu, Kouhei Ohnishi. A quantitative stiffness assessment method in liver biopsy teleoperations. IECON 2013 - 39th Annual Conference of the IEEE Industrial Electronics Society 2013; : 3281 doi: 10.1109/IECON.2013.6699654
50
Steven J. Potts, Johanna K. DiStefano. Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Methods in Pharmacology and Toxicology 2014; : 101 doi: 10.1007/7653_2014_29
51
Mustafa Cengiz, Seren Ozenirler, Sehri Elbeg. Role of serum toll‐like receptors 2 and 4 in non‐alcoholic steatohepatitis and liver fibrosis. Journal of Gastroenterology and Hepatology 2015; 30(7): 1190 doi: 10.1111/jgh.12924
52
Mônica Salum Valverde Borsoi Viana, Kioko Takei, Diva Carvalho Collarile Yamaguti, Betty Guz, Edna Strauss. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Annals of Hepatology 2009; 8(1): 26 doi: 10.1016/S1665-2681(19)31807-1
53
Vincent Leroy, Philippe Halfon, Yannick Bacq, Jérôme Boursier, Marie Christine Rousselet, Marc Bourlière, Anne de Muret, Nathalie Sturm, Gilles Hunault, Guillaume Penaranda, Marie-Claude Bréchot, Candice Trocme, Paul Calès. Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: A meta-analysis with individual data. Clinical Biochemistry 2008; 41(16-17): 1368 doi: 10.1016/j.clinbiochem.2008.06.020
54
Abdel Aziz M. Shaheen, Alex F. Wan, Robert P. Myers. FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy. The American Journal of Gastroenterology 2007; 102(11): 2589 doi: 10.1111/j.1572-0241.2007.01466.x
55
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
56
Elham Ahmed Hassan, Abeer Sharaf El‐Din Abd El‐Rehim, Zain El‐Abdeen Ahmed Sayed, Emad Farah Mohamed Kholef, Abeer Sabry, Noha Abd El‐Rehim Abo Elhagag. VAP score as a novel non‐invasive liver fibrosis model in patients with chronic hepatitis C. Hepatology Research 2017; 47(13): 1408 doi: 10.1111/hepr.12884
57
Jia Cai, Maria Osikowicz, Giada Sebastiani. Clinical significance of elevated liver transaminases in HIV-infected patients. AIDS 2019; 33(8): 1267 doi: 10.1097/QAD.0000000000002233
58
J. Marsillach, S. Parra, N. Ferré, B. Coll, C. Alonso-Villaverde, J. Joven, J. Camps. The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism. 2008; : 187 doi: 10.1007/978-1-4020-6561-3_12
59
Laurent Castera. Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology International 2011; 5(2): 625 doi: 10.1007/s12072-010-9240-0
60
Evangelos Cholongitas, Emmanouel Tsochatzis, John Goulis, Andrew K. Burroughs. Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review. Transplant International 2010; 23(9): 861 doi: 10.1111/j.1432-2277.2010.01142.x
61
Taisa Grotta Ragazzo, Denise Paranagua-Vezozzo, Fabiana Roberto Lima, Daniel Ferraz de Campos Mazo, Mário Guimarães Pessoa, Claudia Pinto Oliveira, Venancio Avancini Ferreira Alves, Flair José Carrilho. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics 2017; 72(9): 516 doi: 10.6061/clinics/2017(09)01
62
Ki M. Mak, Rena Mei. Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease. The Anatomical Record 2017; 300(8): 1371 doi: 10.1002/ar.23567
63
Richard S. Mangus, Michael G. O'Connor, A. Joseph Tector, Joel D. Lim, Rodrigo M. Vianna. Use of the aspartate aminotransferase to platelet ratio index to follow liver fibrosis progression in infants with short gut. Journal of Pediatric Surgery 2010; 45(6): 1266 doi: 10.1016/j.jpedsurg.2010.02.098
64
Ran Cheng, Ning Tan, Hao Luo, Qian Kang, Xiaoyuan Xu. Noninvasive Methods for Detecting Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B: A Single-Center Retrospective Study. Infection and Drug Resistance 2023; : 6323 doi: 10.2147/IDR.S426374
65
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto. Screening strategy for non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2023; 29(Suppl): S103 doi: 10.3350/cmh.2022.0336
66
Antonio Colecchia, Giovanni Marasco, Martina Taddia, Lucia Montrone, Leonardo H. Eusebi, Daniele Mandolesi, Ramona Schiumerini, Anna R. Di Biase, Davide Festi. Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients. European Journal of Gastroenterology & Hepatology 2015; 27(9): 992 doi: 10.1097/MEG.0000000000000393
67
Paul Calès, Fabrice Lainé, Jérôme Boursier, Yves Deugnier, Valérie Moal, Frédéric Oberti, Gilles Hunault, Marie Christine Rousselet, Isabelle Hubert, Jihane Laafi, Pierre Henri Ducluzeaux, Françoise Lunel. Comparison of blood tests for liver fibrosis specific or not to NAFLD. Journal of Hepatology 2009; 50(1): 165 doi: 10.1016/j.jhep.2008.07.035
68
Bo Zhu, Siu-Lung Chan, Jack Li, Kathryn Li, Hao Wu, Kui Cui, Hong Chen. Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.742382
69
A. Biasiolo, L. Chemello, S. Quarta, L. Cavalletto, F. Bortolotti, C. Caberlotto, L. Beneduce, E. Bernardinello, N. Tono, G. Fassina, A. Gatta, P. Pontisso. Monitoring SCCA‐IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis. Journal of Viral Hepatitis 2008; 15(4): 246 doi: 10.1111/j.1365-2893.2007.00935.x
70
Maria Guido. Practical Hepatic Pathology: A Diagnostic Approach. 2011; : 201 doi: 10.1016/B978-0-443-06803-4.00016-2
71
Rachel Gingold-Belfer, Nadav Shinhar, Gil N. Bachar, Nidal Issa, Doron Boltin, Eran Sharon, Tzippy Shohat, Boris Sapoznikov, Ariel Swartz, Noam Peleg, Tom Konikoff, Hemda Schmilovitz-Weiss. Predictors of poor outcome following liver biopsy for the investigation of new hepatic space occupying lesion/s. Clinical Imaging 2023; 99: 19 doi: 10.1016/j.clinimag.2023.04.001
72
Ángel Palacios Pérez, Javier Salmerón Escobar. Papel de la biopsia hepática en el diagnóstico y el control de la hepatitis C crónica. Gastroenterología y Hepatología 2007; 30(7): 402 doi: 10.1157/13108806
73
Mireen Friedrich–Rust, Mei–Fang Ong, Swantje Martens, Christoph Sarrazin, Joerg Bojunga, Stefan Zeuzem, Eva Herrmann. Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis. Gastroenterology 2008; 134(4): 960 doi: 10.1053/j.gastro.2008.01.034
74
Paul Calès, Victor De Ledinghen, Philippe Halfon, Yannick Bacq, Vincent Leroy, Jérôme Boursier, Juliette Foucher, Marc Bourlière, Anne De Muret, Nathalie Sturm, Gilles Hunault, Frédéric Oberti. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver International 2008; 28(10): 1352 doi: 10.1111/j.1478-3231.2008.01789.x
75
Maria Kalafateli, Kurinchi Selvan Gurusamy, Anna H Noel-Storr, Andrew K Burroughs, Emmanuel Tsochatzis. Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C. Cochrane Database of Systematic Reviews 2015;  doi: 10.1002/14651858.CD011929
76
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
77
Basem Hasan Elesawy, Amal Abd El hafez, Laila Shehata Dorgham, Ahmad El-Askary. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Pathology - Research and Practice 2014; 210(12): 922 doi: 10.1016/j.prp.2014.07.005
78
G. Sebastiani, L. Castera, P. Halfon, S. Pol, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Alimentary Pharmacology & Therapeutics 2011; 34(10): 1202 doi: 10.1111/j.1365-2036.2011.04861.x
79
Nikolaos K. Gatselis, George Ntaios, Konstantinos Makaritsis, George N. Dalekos. Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease. Clinical and Experimental Medicine 2014; 14(2): 121 doi: 10.1007/s10238-012-0227-0
80
Steven Shinn-Forng Peng, Yung-Ming Jeng, Wen-Ming Hsu, Justin Cheng-Ta Yang, Ming-Chih Ho. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. European Radiology 2015; 25(10): 2992 doi: 10.1007/s00330-015-3716-1
81
Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese. Molecular Serum Markers of Liver Fibrosis. Biomarker Insights 2012; 7: BMI.S10009 doi: 10.4137/BMI.S10009
82
Laurent Castera. Cirrhosis: A practical guide to management. 2015; : 53 doi: 10.1002/9781118412640.ch06
83
Thierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, Mona Munteanu, Julien Massard, Yves Benhamou, Vlad Ratziu. . Advances in Clinical Chemistry 2008; 46: 131 doi: 10.1016/S0065-2423(08)00404-6
84
P. Calès, J. Boursier, V. de Lédinghen, P. Halfon, Y. Bacq, V. Leroy, N. Dib, F. Oberti, A. Sawadogo, M.-C. Rousselet, F. Lunel. Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroentérologie Clinique et Biologique 2008; 32(12): 1050 doi: 10.1016/j.gcb.2008.09.017
85
Laurent Castera. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Journal of Viral Hepatitis 2009; 16(5): 300 doi: 10.1111/j.1365-2893.2009.01087.x
86
Lidia Monti, Marco Salsano, Manila Candusso, Alfonso Wolfango Avolio, Giovanna Soglia, Marzia Marino, Paola Francalanci, Marco Spada, Paolo Toma. Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging. American Journal of Roentgenology 2020; 215(5): 1229 doi: 10.2214/AJR.19.22057
87
P. Bonnard, A. Elsharkawy, K. Zalata, E. Delarocque‐Astagneau, L. Biard, L. Le Fouler, A. B. Hassan, M. Abdel‐Hamid, M. El‐Daly, M. E. Gamal, M. El Kassas, P. Bedossa, F. Carrat, A. Fontanet, G. Esmat. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV‐genotype 4 in Egypt. Journal of Viral Hepatitis 2015; 22(3): 245 doi: 10.1111/jvh.12285
88
Joseph Misdraji. Changing indications for liver biopsy: viral hepatitis. Diagnostic Histopathology 2014; 20(3): 119 doi: 10.1016/j.mpdhp.2014.01.010
89
Giada Sebastiani, Konstantinos Gkouvatsos, Kostas Pantopoulos. Chronic hepatitis C and liver fibrosis. World Journal of Gastroenterology 2014; 20(32): 11033-11053 doi: 10.3748/wjg.v20.i32.11033
90
Huseyin Kayadibi, Bulent Yasar, Selvinaz Ozkara, Muhittin A. Serdar, Oya O. Kurdas, Can Gonen. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 2014; 74(3): 240 doi: 10.3109/00365513.2013.879392
91
Shuai Gao, Xin‐You Li, Yu‐Chen Fan, Feng‐Kai Sun, Li‐Yan Han, Feng Li, Xiang‐Fen Ji, Kai Wang. A noninvasive model to predict liver histology in HBeAg‐positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal. Journal of Gastroenterology and Hepatology 2017; 32(1): 215 doi: 10.1111/jgh.13452
92
Reine Kanaan, Cesar Yaghi, Carole Saade Riachy, Anders Schlosser, Aline Hamade, Uffe Holmskov, Myrna Medlej‐Hashim, Grith Lykke Sørensen, Rania Jounblat. Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients. JGH Open 2023; 7(3): 197 doi: 10.1002/jgh3.12873
93
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by Noninvasive Biochemical Markers in Egyptian Patients with Chronic Hepatitis B. Euroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
94
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen. Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/231210
95
Zoran Stankovic. Four-dimensional flow magnetic resonance imaging in cirrhosis. World Journal of Gastroenterology 2016; 22(1): 89-102 doi: 10.3748/wjg.v22.i1.89
96
G. Sebastiani, P. Halfon, L. Castera, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti. Comparison of three algorithms of non‐invasive markers of fibrosis in chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2012; 35(1): 92 doi: 10.1111/j.1365-2036.2011.04897.x
97
Urpo Nieminen, Perttu E. T. Arkkila, Päivi Kärkkäinen, Martti A. Färkkilä. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C. Liver International 2009; 29(2): 153 doi: 10.1111/j.1478-3231.2008.01779.x
98
Ahmed Abdel Khalek Abdel Razek, Ahmed Abdalla, Eman Omran, Abeer Fathy, Khaled Zalata. Diagnosis and quantification of hepatic fibrosis in children with diffusion weighted MR imaging. European Journal of Radiology 2011; 78(1): 129 doi: 10.1016/j.ejrad.2009.10.012
99
Dirk J. Van Leeuwen, Charles Balabaud, James M. Crawford, Paulette Bioulac–Sage, Amar P. Dhillon. A Clinical and Histopathologic Perspective on Evolving Noninvasive and Invasive Alternatives for Liver Biopsy. Clinical Gastroenterology and Hepatology 2008; 6(5): 491 doi: 10.1016/j.cgh.2008.02.023
100
Jérôme Boursier, Yannick Bacq, Philippe Halfon, Vincent Leroy, Victor de Ledinghen, Anne de Muret, Marc Bourlière, Nathalie Sturm, Juliette Foucher, Frédéric Oberti, Marie Christine Rousselet, Paul Calès. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2009; 21(1): 28 doi: 10.1097/MEG.0b013e32830cebd7
101
Henry L‐Y Chan, H Janaka De Silva, Nancy W‐Y Leung, Seng‐Gee Lim, Geoffrey C Farrell. How should we manage patients with non‐alcoholic fatty liver disease in 2007?. Journal of Gastroenterology and Hepatology 2007; 22(6): 801 doi: 10.1111/j.1440-1746.2007.04977.x
102
Tamer F. Taha Ali, Mona AbdelGhaffar El Hariri. Diffusion-weighted MRI in liver fibrosis staging: Added value of normalized ADC using spleen and renal cortex as reference organs. The Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(1): 23 doi: 10.1016/j.ejrnm.2016.11.004
103
Hatem A. El-Mezayen, Salem Habib, Hamdi F. Marzok, Mostafa H. Saad. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology 2015; 27(4): 378 doi: 10.1097/MEG.0000000000000298
104
Vlad Pădureanu, Dalia Dop, Alice Drăgoescu, Rodica Pădureanu, Anca Mușetescu, Laurențiu Nedelcu. Non‑alcoholic fatty liver disease and hematologic manifestations (Review). Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10790
105
Abdel Aziz M. Shaheen, Robert P. Myers. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic review. Hepatology 2007; 46(3): 912 doi: 10.1002/hep.21835
106
G. Shiha, S. Seif, A. Eldesoky, M. Elbasiony, R. Soliman, A. Metwally, K. Zalata, N. Mikhail. A simple bedside blood test (Fibrofast; FIB-5) is superior to FIB-4 index for the differentiation between non-significant and significant fibrosis in patients with chronic hepatitis C. Hepatology International 2017; 11(3): 286 doi: 10.1007/s12072-017-9796-z
107
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. cclm 2011; 49(1): 13 doi: 10.1515/CCLM.2011.001
108
Marwa K. Ibrahim, Hosny Salama, Mohamad Abd El Rahman, Reham M. Dawood, Noha G. Bader El Din, Heba F. Salem, Mohamed E.A. Abdelrahim, Dalia Omran, Moataza H. Omran, Khaled Helmi El-Wakeel, Tawfeek H. Abdelhafez, Ahmed Khedr, Mostafa K. El Awady. Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients. Journal of Interferon & Cytokine Research 2016; 36(12): 698 doi: 10.1089/jir.2016.0042
109
Ana Lúcia Coutinho Domingues, Tibério Batista de Medeiros, Edmundo Pessoa de Almeida Lopes. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz 2011; 106(7): 802 doi: 10.1590/S0074-02762011000700004
110
Giada Sebastiani. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World Journal of Gastroenterology 2009; 15(18): 2190-2203 doi: 10.3748/wjg.15.2190
111
Mustafa Cengiz, Seren Ozenirler, Murat Kocabiyik. Serum β-trophin level as a new marker for noninvasive assessment of nonalcoholic fatty liver disease and liver fibrosis. European Journal of Gastroenterology & Hepatology 2016; 28(1): 57 doi: 10.1097/MEG.0000000000000502
112
T. POYNARD, P. HALFON, L. CASTERA, F. CHARLOTTE, B. LE BAIL, M. MUNTEANU, D. MESSOUS, V. RATZIU, Y. BENHAMOU, M. BOURLIÈRE, V. DE LEDINGHEN. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Alimentary Pharmacology & Therapeutics 2007; 25(6): 733 doi: 10.1111/j.1365-2036.2007.03252.x
113
Diana Joka, Kristin Wahl, Sarah Moeller, Jerome Schlue, Bernhard Vaske, Matthias J. Bahr, Michael P. Manns, Klaus Schulze-Osthoff, Heike Bantel. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology 2012; 55(2): 455 doi: 10.1002/hep.24734
114
Yong‐Peng Chen, Xie‐Er Liang. Non‐invasive assessment of liver fibrosis: reduce or substitute the need for liver biopsy?. Liver International 2015; 35(11): 2483 doi: 10.1111/liv.12824
115
Argiro Voumvouraki, Mairi Koulentaki, George Notas, Ourania Sfakianaki, Elias Kouroumalis. Serum surrogate markers of liver fibrosis in primary biliary cirrhosis. European Journal of Internal Medicine 2011; 22(1): 77 doi: 10.1016/j.ejim.2010.10.002
116
Abdelfattah M. Attallah, Mohamed M. Omran, Khaled Farid, Mahmoud El-Bendary, Tarek M. Emran, Mohamed S. Albannan, Ibrahim El-Dosoky. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients. Clinica Chimica Acta 2012; 413(21-22): 1725 doi: 10.1016/j.cca.2012.06.031
117
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver disease. Gene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
118
Xiaolong Qi, Min An, Tongwei Wu, Deke Jiang, Mengyun Peng, Weidong Wang, Jing Wang, Chunqing Zhang, on behalf of the CHESS Study Group. Transient Elastography for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/3406789
119
Mario Rizzetto, Fabien Zoulim. Textbook of Hepatology. 2007; : 819 doi: 10.1002/9780470691861.ch9a
120
Nermin N Salkic, Predrag Jovanovic, Goran Hauser, Majda Brcic. FibroTest/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis. American Journal of Gastroenterology 2014; 109(6): 796 doi: 10.1038/ajg.2014.21
121
Laurent Castera. Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C. Gastroenterology 2012; 142(6): 1293 doi: 10.1053/j.gastro.2012.02.017
122
A. Cequera, M.C. García de León Méndez. Biomarcadores para fibrosis hepática, avances, ventajas y desventajas. Revista de Gastroenterología de México 2014; 79(3): 187 doi: 10.1016/j.rgmx.2014.05.003
123
Mohammad Reza Raoufy, Parviz Vahdani, Seyed Moayed Alavian, Sahba Fekri, Parivash Eftekhari, Shahriar Gharibzadeh. A Novel Method for Diagnosing Cirrhosis in Patients with Chronic Hepatitis B: Artificial Neural Network Approach. Journal of Medical Systems 2011; 35(1): 121 doi: 10.1007/s10916-009-9348-8
124
Thierry Poynard, Patrick Ingiliz, Laure Elkrief, Mona Munteanu, Pascal Lebray, Rachel Morra, Djamila Messous, Francoise Imbert Bismut, Dominique Roulot, Yves Benhamou, Dominique Thabut, Vlad Ratziu, Ji Zhu. Concordance in a World without a Gold Standard: A New Non-Invasive Methodology for Improving Accuracy of Fibrosis Markers. PLoS ONE 2008; 3(12): e3857 doi: 10.1371/journal.pone.0003857
125
Giada Sebastiani, Philippe Halfon, Laurent Castera, Stanislas Pol, David L. Thomas, Alessandra Mangia, Vito Di Marco, Mario Pirisi, Mihai Voiculescu, Maria Guido, Marc Bourliere, Franco Noventa, Alfredo Alberti. SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49(6): 1821 doi: 10.1002/hep.22859
126
Carlo Fabris, Carlo Smirne, Pierluigi Toniutto, Cosimo Colletta, Rachele Rapetti, Rosalba Minisini, Edmondo Falleti, Monica Leutner, Mario Pirisi. Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C. Clinical Chemical Laboratory Medicine 2008; 46(2) doi: 10.1515/CCLM.2008.051
127
Wei Liu, Xiaosong Li, Weihong Zheng, Rucheng Yao, Jun Zheng. Preoperative evaluation of the degree of liver fibrosis based on matter-element analysis using serological indicators in patients with hepatocellular carcinoma. BioScience Trends 2019; 13(1): 70 doi: 10.5582/bst.2018.01311
128
Kristin Wahl, William Rosenberg, Bernhard Vaske, Michael P. Manns, Klaus Schulze-Osthoff, Matthias J. Bahr, Heike Bantel, Matias A. Avila. Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography. PLoS ONE 2012; 7(12): e51906 doi: 10.1371/journal.pone.0051906
129
Pamela Valva, Paola Casciato, Juan M. Diaz Carrasco, Adrian Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. The Role of Serum Biomarkers in Predicting Fibrosis Progression in Pediatric and Adult Hepatitis C Virus Chronic Infection. PLoS ONE 2011; 6(8): e23218 doi: 10.1371/journal.pone.0023218
130
Maria Papastamataki, Polyxeni Delaporta, Evangelos Premetis, Antonios Kattamis, Vassilios Ladis, Ioannis Papassotiriou. Evaluation of liver fibrosis in patients with thalassemia: The important role of hyaluronic acid. Blood Cells, Molecules, and Diseases 2010; 45(3): 215 doi: 10.1016/j.bcmd.2010.06.002
131
O.A. Gressner, R. Weiskirchen, A.M. Gressner. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre‐disposition pending between fiction and reality. Journal of Cellular and Molecular Medicine 2007; 11(5): 1031 doi: 10.1111/j.1582-4934.2007.00092.x
132
EL-Shahat A. Toson, Gamal E. Shiha, Asmaa E. Abdelgaleel. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Annals of Hepatology 2017; 16(6): 862 doi: 10.5604/01.3001.0010.5276
133
Oluwole S. Owojuyigbe, Christopher Larbie, Caleb K. Firempong, Gustav Komlaga, Benjamin O. Emikpe, Ademola A. Oyagbemi. Hura crepitans stem bark extract: A potential remedy to sub-acute liver damage. Journal of Ethnopharmacology 2022; 284: 114768 doi: 10.1016/j.jep.2021.114768
134
M. Bourlière, A. Kahloun, G. Gascou-Tessonnier. Analogs and fibrosis regression in hepatitis B. Gastroentérologie Clinique et Biologique 2009; 33(10-11): 923 doi: 10.1016/j.gcb.2009.06.003
135
Fatma Demet Arslan, Inanc Karakoyun, Bengu Tatar, Emel Ebru Pala, Mustafa Yıldırım, Celal Ulasoglu, Can Duman, Harun Akar, Sukran Kose, Banu Isbilen Basok. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63310
136
Grazia Pennisi, Antonina Giammanco, Salvatore Petta. Elastography of the Liver and Beyond. 2021; : 61 doi: 10.1007/978-3-030-74132-7_5
137
Pamela Valva, Daniela A Ríos, Elena De Matteo, Maria V Preciado. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World Journal of Gastroenterology 2016; 22(4): 1367-1381 doi: 10.3748/wjg.v22.i4.1367
138
Yunpeng Sun, Xue Shan, Jiantao Guo, Xuguang Liu, Dashi Ma. CHI3L1 promotes myocardial fibrosis via regulating lncRNA TUG1/miR-495-3p/ETS1 axis. Apoptosis 2023; 28(9-10): 1436 doi: 10.1007/s10495-023-01859-9
139
Paul Calès, Pascal Veillon, Anselme Konaté, Elisabeth Mathieu, Catherine Ternisien, Alain Chevailler, Alban Godon, Yves Gallois, Françoise Joubaud, Isabelle Hubert-Fouchard, Frédéric Oberti, Stéphane Réaud, Gilles Hunault, Françoise Mauriat, Françoise Lunel-Fabiani. Reproducibility of blood tests of liver fibrosis in clinical practice. Clinical Biochemistry 2008; 41(1-2): 10 doi: 10.1016/j.clinbiochem.2007.08.009
140
Ki M. Mak, Chien Yi M. Png, Danielle J. Lee. Type V Collagen in Health, Disease, and Fibrosis. The Anatomical Record 2016; 299(5): 613 doi: 10.1002/ar.23330
141
Mona El-Hariri, Tamer F. Taha Ali, Hala I.M. Hussien. Apparent diffusion coefficient (ADC) in liver fibrosis: Usefulness of normalized ADC using the spleen as reference organ. The Egyptian Journal of Radiology and Nuclear Medicine 2013; 44(3): 441 doi: 10.1016/j.ejrnm.2013.05.008
142
Leah M. Norona, Deborah G. Nguyen, David A. Gerber, Sharon C. Presnell, Edward L. LeCluyse. Editor’s Highlight: Modeling Compound-Induced FibrogenesisIn VitroUsing Three-Dimensional Bioprinted Human Liver Tissues. Toxicological Sciences 2016; 154(2): 354 doi: 10.1093/toxsci/kfw169
143
Seung Kak Shin, Jeong Han Kim, Hyeonsu Park, Oh Sang Kwon, Hyun Jung Lee, Jong Eun Yeon, Kwan Soo Byun, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim. Improvement of liver function and non‐invasive fibrosis markers in hepatitis B virus‐associated cirrhosis: 2 years of entecavir treatment. Journal of Gastroenterology and Hepatology 2015; 30(12): 1775 doi: 10.1111/jgh.13020
144
Gian Paolo Caviglia, Alessia Ciancio, Chiara Rosso, Maria Lorena Abate, Antonella Olivero, Rinaldo Pellicano, Giovanni Antonio Touscoz, Antonina Smedile, Mario Rizzetto. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Annals of Hepatology 2014; 13(1): 91 doi: 10.1016/S1665-2681(19)30909-3
145
Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Hans Van Vlierberghe. Proteomics in liver fibrosis is more than meets the eye. European Journal of Gastroenterology & Hepatology 2008; 20(5): 450 doi: 10.1097/MEG.0b013e3282f4de92
146
T. Poynard, M. Muntenau, R. Morra, Y. Ngo, F. Imbert-Bismut, D. Thabut, D. Messous, J. Massard, P. Lebray, J. Moussalli, Y. Benhamou, V. Ratziu. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroentérologie Clinique et Biologique 2008; 32(6): 8 doi: 10.1016/S0399-8320(08)73990-3
147
Laurent Castera. Viral Hepatitis. 2013; : 341 doi: 10.1002/9781118637272.ch23
148
Mireen Friedrich-Rust, William Rosenberg, Julie Parkes, Eva Herrmann, Stefan Zeuzem, Christoph Sarrazin. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterology 2010; 10(1) doi: 10.1186/1471-230X-10-103
149
Pamela Valva, Paola Casciato, Carol Lezama, Marcela Galoppo, Adrián Gadano, Omar Galdame, María Cristina Galoppo, Eduardo Mullen, Elena De Matteo, María Victoria Preciado, Ravi Jhaveri. Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children. PLoS ONE 2013; 8(1): e53519 doi: 10.1371/journal.pone.0053519
150
Václav Ceplecha, Kristína Řeháková, Corinne Lendon, Pavel Proks, Miša Škorič, Guy C.M. Grinwis, Barbora Hřibová, Miloš Vávra, Jana Lorenzová, Michal Crha. Hyaluronic acid and TGF-β1 in dogs with hepatobiliary diseases. Acta Veterinaria Brno 2018; 87(3): 231 doi: 10.2754/avb201887030231
151
Tamara Alempijevic, Miodrag Krstic, Rada Jesic, Ivan Jovanovic, Aleksandra Sokic Milutinovic, Nada Kovacevic, Slobodan Krstic, Dragan Popovic. Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis. World Journal of Gastroenterology 2009; 15(5): 591-594 doi: 10.3748/wjg.15.591
152
Laurent Castéra, Brigitte Le Bail, Françoise Roudot-Thoraval, Pierre-Henri Bernard, Juliette Foucher, Wassil Merrouche, Patrice Couzigou, Victor de Lédinghen. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of Hepatology 2009; 50(1): 59 doi: 10.1016/j.jhep.2008.08.018
153
El-Shatat A. Toson, Gamal E. Shiha, Hatem A. El-Mezayen, Aml M. El-Sharkawy. Diagnostic performance of T lymphocyte subpopulations in assessment of liver fibrosis stages in hepatitis C virus patients: simple noninvasive score. European Journal of Gastroenterology & Hepatology 2016; 28(8): 931 doi: 10.1097/MEG.0000000000000656
154
Harun ERDAL, Ayfer BAKIR, Mustafa GÜNEY, Armağan GÜNAL, Mustafa GÜLŞEN. Relationship between Histopathological Stages of Liver and Albumin-Bilirubin Score in Hepatitis B Infection. Düzce Tıp Fakültesi Dergisi 2022; 24(1): 60 doi: 10.18678/dtfd.1055076
155
Evangelos Cholongitas, Andrew K Burroughs, Amar P Dhillon. Evidence‐Based Gastroenterology and Hepatology. 2010; : 762 doi: 10.1002/9781444314403.ch46
156
Ching-Sheng Hsu, Jia-Horng Kao. Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan. Journal of the Formosan Medical Association 2012; 111(10): 527 doi: 10.1016/j.jfma.2012.07.002
157
Giada Sebastiani, Alfredo Alberti. Non-invasive markers of liver fibrosis: How to use them in clinical practice?. Journal of Hepatology 2007; 46(3): 529 doi: 10.1016/j.jhep.2006.12.003
158
Andrew K. Burroughs, Evangelos Cholongitas. Non-invasive tests for liver fibrosis: Encouraging or discouraging results?. Journal of Hepatology 2007; 46(5): 751 doi: 10.1016/j.jhep.2007.02.017
159
An-Na Pan, Wang-Wang Xu, Yun-Lin Luo, Huan-Huan Yu, Yi-Bing Hu, Qing-Feng Sun, Ji-Guang Ding, Yang-He Wu. A novel system for predicting liver histopathology in patients with chronic hepatitis B. Medicine 2017; 96(14): e6465 doi: 10.1097/MD.0000000000006465
160
Catherine Jane Messner, Carine Premand, Carine Gaiser, Tanja Kluser, Eric Kübler, Laura Suter-Dick. Exosomal microRNAs Release as a Sensitive Marker for Drug-Induced Liver InjuryIn Vitro. Applied In Vitro Toxicology 2020; 6(3): 77 doi: 10.1089/aivt.2020.0008
161
Jorge-Shmuel Delgado. Evolving trends in nonalcoholic fatty liver disease. European Journal of Internal Medicine 2008; 19(2): 75 doi: 10.1016/j.ejim.2007.02.034
162
Mario Plebani, Daniela Basso. Non-invasive assessment of chronic liver and gastric diseases. Clinica Chimica Acta 2007; 381(1): 39 doi: 10.1016/j.cca.2007.02.019
163
Hakan Fotbolcu, Elçin Zorlu. Nonalcoholic fatty liver disease as a multi-systemic disease. World Journal of Gastroenterology 2016; 22(16): 4079-4090 doi: 10.3748/wjg.v22.i16.4079
164
M. H. JARRAR, A. BARANOVA, R. COLLANTES, B. RANARD, M. STEPANOVA, C. BENNETT, Y. FANG, H. ELARINY, Z. GOODMAN, V. CHANDHOKE, Z. M. YOUNOSSI. Adipokines and cytokines in non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2008; 27(5): 412 doi: 10.1111/j.1365-2036.2007.03586.x
165
T. Poynard. Faut-il encore faire des biopsies du foie ?. La Revue de Médecine Interne 2007; 28(2): 67 doi: 10.1016/j.revmed.2006.09.003
166
Charles S. Lieber, David G. Weiss, Fiorenzo Paronetto. Value of Fibrosis Markers for Staging Liver Fibrosis in Patients With Precirrhotic Alcoholic Liver Disease. Alcoholism: Clinical and Experimental Research 2008; 32(6): 1031 doi: 10.1111/j.1530-0277.2008.00664.x
167
Mortada Hassan El-Shabrawi, Mona Isa. Noninvasive Methods to Evaluate Liver Fibrosis in Chronic HCV Infection. Hepatitis Monthly 2011; 11(9): 758 doi: 10.5812/kowsar.1735143X.1377
168
Daiki Suzuki, Yoshitomo Matsumi, Kouhei Ohnishi. An analysis on force data during biopsy insertion. 2014 IEEE 13th International Workshop on Advanced Motion Control (AMC) 2014; : 422 doi: 10.1109/AMC.2014.6823319
169
Ancha Baranova, Priyanka Lal, Aybike Birerdinc, Zobair M Younossi. Non-Invasive markers for hepatic fibrosis. BMC Gastroenterology 2011; 11(1) doi: 10.1186/1471-230X-11-91
170
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai‐Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius‐Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non‐invasive assessment of liver fibrosis in chronic viral hepatitis. European Journal of Clinical Investigation 2015; 45(12): 1243 doi: 10.1111/eci.12543
171
Mustafa Kula, Seyhan Karacavus, Mevlut Baskol, Kemal Deniz, Ummuhan Abdulrezzak, Ahmet Tutus. Hepatobiliary function assessed by 99mTc-mebrofenin cholescintigraphy in the evaluation of fibrosis in chronic hepatitis: histopathological correlation. Nuclear Medicine Communications 2010; 31(4): 280 doi: 10.1097/MNM.0b013e328334bff7
172
Laurent Castera. Assessing liver fibrosis. Expert Review of Gastroenterology & Hepatology 2008; 2(4): 541 doi: 10.1586/17474124.2.4.541
173
Giada Sebastiani, Kostas Pantopoulos. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice. Metallomics 2011; 3(10): 971 doi: 10.1039/c1mt00082a
174
Nermin N. Salkic, Elmir Cickusic, Predrag Jovanovic, Mirela Basic Denjagic, Samra Iljazovic-Topcic, Milenko Bevanda, Sead Ahmetagic. Online combination algorithm for non-invasive assessment of chronic hepatitis B related liver fibrosis and cirrhosis in resource-limited settings. European Journal of Internal Medicine 2015; 26(8): 628 doi: 10.1016/j.ejim.2015.07.005
175
Jerome Lambert, Philippe Halfon, Guillaume Penaranda, Pierre Bedossa, Patrice Cacoub, Fabrice Carrat. How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited. Clinical Chemistry 2008; 54(8): 1372 doi: 10.1373/clinchem.2007.097923
176
Sreelakshmi Kotha, ShuetFong Neong, Keyur Patel. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2018; 18(8): 713 doi: 10.1080/14737159.2018.1496020
177
Mustafa Cengiz, Seren Ozenirler. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1293 doi: 10.1097/MEG.0000000000000445
178
Manuel Romero-Gómez, Emilio Gómez-González, Ana Madrazo, Marina Vera-Valencia, Luis Rodrigo, Ramón Pérez-Alvarez, Rosa Pérez-López, Victor M. Castellano-Megias, Manuel Nevado-Santos, Juan C. Alcón, Ricard Solá, José M. Pérez-Moreno, José M. Navarro, Raúl J. Andrade, Javier Salmerón, Manuel Fernández-López, Rafael Aznar, Moisés Diago. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology 2008; 47(3): 810 doi: 10.1002/hep.22112
179
Laurent Castera. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Practice & Research Clinical Gastroenterology 2011; 25(2): 291 doi: 10.1016/j.bpg.2011.02.003
180
Thierry Poynard, Victor de Ledinghen, Jean-Pierre Zarski, Carol Stanciu, Mona Munteanu, Julien Vergniol, Julie France, Anca Trifan, Joseph Moussalli, Pascal Lebray, Dominique Thabut, Vlad Ratziu. FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate. Clinics and Research in Hepatology and Gastroenterology 2011; 35(11): 720 doi: 10.1016/j.clinre.2011.07.003
181
T. Poynard, Y. Ngo, P. Marcellin, S. Hadziyannis, V. Ratziu, Y. Benhamou. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus. Journal of Viral Hepatitis 2009; 16(3): 203 doi: 10.1111/j.1365-2893.2008.01065.x
182
María Eugenia Constantino. Naturaleza y grafía. El <em>corpus</em> documental de las colecciones animales en el Real Gabinete de Madrid, 1752-1790. Asclepio 2015; 67(2): p110 doi: 10.3989/asclepio.2015.28
183
Thierry Poynard, Nezam H Afdhal. Perspectives on Fibrosis Progression in Hepatitis C: An à la Carte Approach to Risk Factors and Staging of Fibrosis. Antiviral Therapy 2010; 15(3): 281 doi: 10.3851/IMP1535
184
Measurement of Soft Tissue Elasticity in Vivo. 2015; : 156 doi: 10.1201/b19032-13
185
Patrick Ingiliz, Kim Pav Chhay, Mona Munteanu, Pascal Lebray, Yen Ngo, Dominique Roulot, Yves Benhamou, Dominique Thabut, Vlad Ratziu, Thierry Poynard. Applicability and variability of liver stiffness measurements according to probe position. World Journal of Gastroenterology 2009; 15(27): 3398-3404 doi: 10.3748/wjg.15.3398
186
Xie Er Liang, Chunxiu Zhong, Liwen Huang, Shuling Yang, Youfu Zhu, Yongpeng Chen, Jinlin Hou. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers. Journal of Gastroenterology and Hepatology 2017; 32(2): 459 doi: 10.1111/jgh.13475
187
Yong-Peng Chen, Jie Peng, Jin-Lin Hou. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatology International 2013; 7(2): 356 doi: 10.1007/s12072-013-9439-y
188
V. RATZIU, P. GIRAL, M. MUNTEANU, D. MESSOUS, A. MERCADIER, M. BERNARD, R. MORRA, F. IMBERT‐BISMUT, E. BRUCKERT, T. POYNARD. Screening for liver disease using non‐invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. Alimentary Pharmacology & Therapeutics 2007; 25(2): 207 doi: 10.1111/j.1365-2036.2006.03182.x
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345